Correlation Between MediciNova and Shattuck Labs
Can any of the company-specific risk be diversified away by investing in both MediciNova and Shattuck Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Shattuck Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Shattuck Labs, you can compare the effects of market volatilities on MediciNova and Shattuck Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Shattuck Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Shattuck Labs.
Diversification Opportunities for MediciNova and Shattuck Labs
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between MediciNova and Shattuck is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Shattuck Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shattuck Labs and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Shattuck Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shattuck Labs has no effect on the direction of MediciNova i.e., MediciNova and Shattuck Labs go up and down completely randomly.
Pair Corralation between MediciNova and Shattuck Labs
Given the investment horizon of 90 days MediciNova is expected to generate 0.94 times more return on investment than Shattuck Labs. However, MediciNova is 1.06 times less risky than Shattuck Labs. It trades about 0.08 of its potential returns per unit of risk. Shattuck Labs is currently generating about -0.15 per unit of risk. If you would invest 165.00 in MediciNova on September 3, 2024 and sell it today you would earn a total of 42.00 from holding MediciNova or generate 25.45% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
MediciNova vs. Shattuck Labs
Performance |
Timeline |
MediciNova |
Shattuck Labs |
MediciNova and Shattuck Labs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MediciNova and Shattuck Labs
The main advantage of trading using opposite MediciNova and Shattuck Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Shattuck Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shattuck Labs will offset losses from the drop in Shattuck Labs' long position.MediciNova vs. DiaMedica Therapeutics | MediciNova vs. Lyra Therapeutics | MediciNova vs. Centessa Pharmaceuticals PLC |
Shattuck Labs vs. C4 Therapeutics | Shattuck Labs vs. Eliem Therapeutics | Shattuck Labs vs. Prelude Therapeutics | Shattuck Labs vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |